Former Food and Drug Administration commissioner Mark McClellan voiced strong doubts about a proposal to make the “morning after pill” more easily accessible months before the agency overrode the advice of its staff and an expert panel and rejected the application, government investigators reported today.

The Government Accountability Office report said the apparent involvement of McClellan and other top officials was one of four unusual aspects of FDA’s handling of the politically sensitive decision. The investigators reported that several key FDA officials told colleagues that the application to allow over-the-counter sales of the emergency contraceptive would be rejected months before the decision was announced.

Click here for link.